AVEO - AVEO Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-7,5792,51519,024
Cost of Revenue20,65225,17923,70312,875
Gross Profit-15,243-17,600-21,1886,149
Operating Expenses
Research Development----
Selling General and Administrative-9,1388,20510,217
Non Recurring----
Total Operating Expenses-34,31731,90823,092
Operating Income or Loss--26,738-29,393-4,068
Income from Continuing Operations
Total Other Income/Expenses Net22,886-38,1862,607-10,933
Earnings Before Interest and Taxes--26,738-29,393-4,068
Interest Expense--2,373-1,949-2,286
Income Before Tax--64,924-26,786-15,001
Income Tax Expense-101101-
Minority Interest----
Net Income From Continuing Ops--65,025-26,887-15,001
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--65,025-26,887-15,001
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--65,025-26,887-15,001